Cerebral Protection System Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2022 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Cerebral Protection System Market: By Products (Clarets Sentinel System, Keystone Hearts Triguard Device, and Embrella Embolic Deflector), By Application (Cardiovascular Disease and Peripheral Disease), and by Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Cerebral Protection System Market size was valued at USD 726.5 Million in 2021 and is poised to grow at a significant CAGR of 9.2% over 2022–2028. The main treatment option for severe aortic stenosis that cannot be operated on or present a high surgical risk is transcatheter aortic valve implantation (TAVI). According to diffusion-weighted MRI research, certain silent brain infarcts develop following TAVI and cause subsequent mental decline. During TAVI, embolic protection devices provide a mechanical barrier against the debris that can induce brain embolization. The risk of cerebrovascular events associated with TAVI has decreased because of these devices. The market is growing due to an increase in the geriatric population, adoption of cutting-edge surgical procedures, and investments in health care. Technological development in embolic protection devices will contribute to corporate growth in a beneficial way. Technological developments that resulted in the creation of enhanced embolic protection devices for TAVI like CLEAN-TAVI offer a variety of prospects for the market’s expansion. The market will grow if companies concentrate on creating new and cost-effective technologies for instance, the double-occlusion balloon system in Medtronic’s Mo. Ma Ultra proximal cerebral protection device ensures proximal embolic protection before crossing a carotid lesion. The market for cerebral protection devices will expand due to the development of these products. Furthermore, favorable reimbursement policies for these systems will boost business growth by increasing usage.

Recent Market Developments:

In March 2020, The TriGUARD 3 TM Cerebral Embolic Protection (CEP) Device has received European CE Mark from Keystone Heart Ltd., a Venus MedTech Company. During Transcatheter Aortic Valve Implantation (TAVI) and other transcatheter cardiac procedures, the device is meant to divert embolic material away from cerebral circulation, reducing the risk of brain injury.

The TriGUARD 3TM Cerebral Embolic Protection Device was used for the first time in a commercial case in the world, according to Keystone Heart, a Venus MedTech company.

For $300 million, Venus MedTech (Hangzhou) Inc. bought a 100 percent stock interest and corresponding equity in Cardio valve Ltd. Cardio valve, established in Yehuda, Israel, makes the Cardio valve system, which is a transcatheter interventional replacement solution for mitral or tricuspid regurgitation.

Cerebral Protection System Market

MARKET SUMMARY
-
9.2%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 9.2%
  • Largest Market– Asia Pacific
  • Fastest Growing Market– North America

Cerebral Protection System Market

  • The report on global cerebral protection system market gives historical, current and future market sizes (US$ Mn) on the basis of  type, and geography
  • The cerebral protection system market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Allium Medica
  • Boston Scientific
  • Cardinal Health
  • Contego Medical
  • Gore Medical
Cerebral Protection System Market Dynamics

Global cerebral thrombotic protection devices are used to protect the brain before, during, and after TAVI in hospitals (TAVR). The gadget inflates a balloon in the left atrium or inside the heart. Using global cerebral embolic protection devices for TAVI at home aims to reduce the risk of heart attack and stroke, enabling patients to avoid going to the hospital and instead stay at home. However, the market’s expansion is anticipated to be hampered by the high cost of devices & systems and a strict regulatory environment might limit the development of the embolic protection devices market.


North-America Got Significant Share

Cerebral Protection System Market

The cerebral protection system market in North America is likely to hold a significant revenue share in 2021, and, in the following years, it is predicted to increase rapidly. During the anticipated period, the market for embolic protection devices will be driven by the rising burden of chronic diseases in developed and developing nations. Over 92 million Americans are said to be affected by cardiovascular disease, according to the American Heart Association. Additionally, almost 2,300 Americans die from cardiovascular disease daily in the United States. The need for various surgical and non-surgical therapies would increase due to the rising prevalence of cardiovascular illnesses. Therefore, factors that will speed up the expansion of the industry in the following years include the increasing acceptance of embolic protection devices to trap and remove debris that may be extricated during procedures.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The cerebral protection system market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Cerebral Protection System Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The cerebral protection system market is projected to expand at a CAGR of 9.2% during the forecast period

Praxair Inc., AMCS Corporation, The Linde Group, Iwatani Corporation, Messer Group GmbH

North America is the fastest-growing region for cerebral protection system market


Report

Company Profile

  • Keystone Heart
  • Claret Medical, Inc.
  • Edwards Lifesciences Corporation
  • Abbott Laboratories
  • Allium Medica
  • Boston Scientific
  • Cardinal Health
  • Contego Medical
  • Gore Medical
  • Medtronic

Description

Cerebral Protection System Market size was valued at USD 726.5 Million in 2021 and is poised to grow at a significant CAGR of 9.2% over 2022–2028. The main treatment option for severe aortic stenosis that cannot be operated on or present a high surgical risk is transcatheter aortic valve implantation (TAVI). According to diffusion-weighted MRI research, certain silent brain infarcts develop following TAVI and cause subsequent mental decline. During TAVI, embolic protection devices provide a mechanical barrier against the debris that can induce brain embolization. The risk of cerebrovascular events associated with TAVI has decreased because of these devices. The market is growing due to an increase in the geriatric population, adoption of cutting-edge surgical procedures, and investments in health care. Technological development in embolic protection devices will contribute to corporate growth in a beneficial way. Technological developments that resulted in the creation of enhanced embolic protection devices for TAVI like CLEAN-TAVI offer a variety of prospects for the market’s expansion. The market will grow if companies concentrate on creating new and cost-effective technologies for instance, the double-occlusion balloon system in Medtronic’s Mo. Ma Ultra proximal cerebral protection device ensures proximal embolic protection before crossing a carotid lesion. The market for cerebral protection devices will expand due to the development of these products. Furthermore, favorable reimbursement policies for these systems will boost business growth by increasing usage.

Recent Market Developments:

In March 2020, The TriGUARD 3 TM Cerebral Embolic Protection (CEP) Device has received European CE Mark from Keystone Heart Ltd., a Venus MedTech Company. During Transcatheter Aortic Valve Implantation (TAVI) and other transcatheter cardiac procedures, the device is meant to divert embolic material away from cerebral circulation, reducing the risk of brain injury.

The TriGUARD 3TM Cerebral Embolic Protection Device was used for the first time in a commercial case in the world, according to Keystone Heart, a Venus MedTech company.

For $300 million, Venus MedTech (Hangzhou) Inc. bought a 100 percent stock interest and corresponding equity in Cardio valve Ltd. Cardio valve, established in Yehuda, Israel, makes the Cardio valve system, which is a transcatheter interventional replacement solution for mitral or tricuspid regurgitation.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX